You are required to be logged in to access the full website
Click here if you have forgotten your username or password
28 September 2026 - Netherlands-based holding company QIAGEN N.V. (NYSE:QGEN) (Frankfurt Prime Standard:QIA) announced on Monday that it has received US Food and Drug Administration (FDA) clearance for a new QIAstat-Dx panel, giving US laboratories a...
28 September 2026 - Cambridge-based biotechnology company 4basebio PLC (AIM: 4BB) reported on Monday that it is to supply clinical-grade opDNA synthetic DNA for a multinational pharmaceutical company's Phase I cell therapy programme, extending a...
28 September 2026 - Kodiak Sciences Inc (Nasdaq:KOD), a precommercial retina-focused biotechnology company, said on Friday that the company will report topline results from DAYBREAK, a Phase 3 study evaluating both Zenkuda (tarcocimab tedromer) and K...
28 September 2026 - Chinese commercial-stage biopharmaceutical company IASO Biotechnology (IASO Bio) announced on Saturday the presentation of first-in-human (FIH) Phase 1 clinical data for IASO206, its internally developed BCMA-targeted in vivo CAR-...
28 September 2026 - Radiotherapy technology company Leo Cancer Care on Sunday announced plans to further invest in the treatment experience for children undergoing radiation therapy.Following the world's first paediatric treatments using an upri...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe